We are live on
!
Find out more
BFO
Boston Family Office Portfolio holdings
AUM
$1.65B
1-Year Est. Return
18.1%
This Fund
S&P 500
This Quarter
Est. Return
-0.22%
1 Year Est. Return
+18.1%
3 Year Est. Return
+53.4%
5 Year Est. Return
+63.18%
10 Year Est. Return
+288.04%
AUM
$777M
AUM Growth
-$10.7M
(-1.4%)
Cap. Flow
-$2.88M
Cap. Flow
% of AUM
-0.37%
Top 10 Holdings %
Top 10 Hldgs %
22.01%
Holding
267
New
2
Increased
69
Reduced
89
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$1.46M |
| 2 |
AGN
Allergan plc
AGN
|
+$662K |
| 3 |
Walt Disney
DIS
|
+$472K |
| 4 |
Weyerhaeuser
WY
|
+$319K |
| 5 |
ATW
Atwood Oceanics
ATW
|
+$311K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VIVO
Meridian Bioscience Inc
VIVO
|
+$2.13M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$880K |
| 3 |
AbbVie
ABBV
|
+$539K |
| 4 |
NLSN
Nielsen Holdings plc
NLSN
|
+$388K |
| 5 |
State Street SPDR S&P China ETF
GXC
|
+$361K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.02% |
| 2 | Miscellaneous | 14.73% |
| 3 | Industrials | 14.1% |
| 4 | Technology | 12.24% |
| 5 | Consumer Staples | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Saic
SAIC
$5.6B
| $203K | 0.03% |
4,585
| – | – |
|
252
Clean Energy Fuels
CLNE
$395M
| $90K | 0.01% |
11,550
| – | – |
|
|
SDEV
253
Stablecoin Development Corp
SDEV
$44.8M
| – | – |
0
| – | – |
|
254
Avery Dennison
AVY
$12.9B
| – | – |
-4,250
| Closed | -$218K |
|
255
iShares MSCI Europe Small-Cap ETF
IEUS
$174M
| – | – |
-4,400
| Closed | -$207K |
|
256
Suncor Energy
SU
$84B
| – | – |
-4,700
| Closed | -$200K |
|
|
VIVO
257
DELISTED
Meridian Bioscience Inc
VIVO
| – | – |
-103,174
| Closed | -$2.13M |
|
|
QEP
258
DELISTED
QEP RESOURCES, INC.
QEP
| – | – |
-6,400
| Closed | -$221K |
|
|
DNB
259
DELISTED
Dun & Bradstreet
DNB
| – | – |
-1,902
| Closed | -$210K |
|
|
LLTC
260
DELISTED
Linear Technology Corp
LLTC
| – | – |
-4,365
| Closed | -$205K |
|
|
CYBX
261
DELISTED
CYBERONICS INC
CYBX
| – | – |
-3,600
| Closed | -$225K |
|
|
NLSN
262
DELISTED
Nielsen Holdings plc
NLSN
| – | – |
-8,025
| Closed | -$388K |
|
|
FRX
263
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
-8,890
| Closed | -$880K |
|
Similar funds
MCIL
BCM
SOS
GS
NPA
AAM
OHIF
SCM
Boston Family Office's Q3 2014 Portfolio in Review
As of Q3 2014, Boston Family Office held 267 positions worth $777M, down 1.4% from $788M the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 4.5%. Boston Family Office opened 2 new positions and exited 10, leaving the 267-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Industrials.
- Boston Family Office's largest Q3 2014 buy was Allergan plc: 2,957 shares worth $713K.
- Boston Family Office added most to Verizon in Q3 2014, an estimated $1.46M increase.
- Boston Family Office's biggest Q3 2014 reduction was AbbVie, cutting an estimated $539K.
- Boston Family Office fully exited Meridian Bioscience Inc in Q3 2014, selling an estimated $2.13M.
- Boston Family Office's ten largest holdings make up 22% of its $777M portfolio in Q3 2014.
- Boston Family Office opened 2 new positions and closed 10 in Q3 2014.
- Boston Family Office's portfolio value fell 1.4% quarter-over-quarter to $777M.
Based on Boston Family Office's 13F filing for Q3 2014, filed 31 Oct 2014.